World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
33282
World Ranking
9680
National Ranking
4982

Douglas Yee publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Douglas Yee sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 423 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Douglas Yee D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Douglas Yee sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Douglas Yee is affiliated with the University of Minnesota in the United States and has contributed extensively to research in Medicine and Biochemistry, Genetics and Molecular Biology. Their work primarily focuses on Oncology, Cancer Research, Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Pulmonary and Respiratory Medicine.

The scientist's research topics include Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Cancer Genomics and Diagnostics, Cancer Treatment and Pharmacology, Cancer Immunotherapy and Biomarkers, and Growth Hormone and Insulin-like Growth Factors.

Douglas Yee has been involved in publishing research in a variety of respected journals, with frequent appearances in Cancer Research, Journal of Clinical Oncology, Annals of Surgical Oncology, JAMA Oncology, and Annals of Oncology.

Recent notable papers include:

  • Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer (2020, JAMA Oncology)
  • Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer (2020, JAMA Oncology)
  • Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial (2021, Cancer Cell)
  • Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies (2022, Cancer Cell)
  • Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy (2023, Cancer Cell)

Douglas Yee has collaborated frequently with several co-authors, including Christina Yau, Laura J. Esserman, Angela DeMichele, Claudine Isaacs, and Laura van 't Veer.

Best Publications

  • Diabetes and Cancer: A consensus report

    Edward L. Giovannucci;David M. Harlan;Michael C. Archer;Richard M. Bergenstal

  • APOBEC3B is an enzymatic source of mutation in breast cancer

    Michael B. Burns;Lela Lackey;Michael A. Carpenter;Anurag Rathore

  • Morphine Stimulates Angiogenesis by Activating Proangiogenic and Survival-promoting Signaling and Promotes Breast Tumor Growth

    Kalpna Gupta;Smita Kshirsagar;Liming Chang;Robert Schwartz

  • Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins.

    Marta Guix;Anthony C. Faber;Shizhen Emily Wang;Maria Graciela Olivares

  • Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

    Rita Nanda;Minetta C Liu;Christina Yau;Rebecca Shatsky

  • Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

    Hope S. Rugo;Olufunmilayo I. Olopade;Angela DeMichele;Christina Yau

  • Disrupting Insulin-Like Growth Factor Signaling as a Potential Cancer Therapy

    D. Sachdev;D. Yee

  • Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer

    Douglas Yee;Soonmyoung Paik;Soonmyoung Paik;Gail S. Lebovic;Gail S. Lebovic;Rachel R. Marcus;Rachel R. Marcus

  • Randomized Controlled Trial of Weight Training and Lymphedema in Breast Cancer Survivors

    Rehana L. Ahmed;William Thomas;Douglas Yee;Kathryn H. Schmitz

  • Insulin-like Growth Factor Receptor Expression and Function in Human Breast Cancer

    Kevin J. Cullen;Douglas Yee;William S. Sly;James Perdue

  • Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.

    A. V. Lee;J. G. Jackson;J. L. Gooch;S. G. Hilsenbeck

  • Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells.

    Svetlana Avdulov;Shunan Li;Van Michalek;David Burrichter

  • Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer: Predicting Response with in Vivo 1H MR Spectroscopy—A Pilot Study at 4 T

    Sina Meisamy;Patrick J Bolan;Eva H Baker;Robin L Bliss

  • The IGF system and breast cancer.

    Deepali Sachdev;Douglas Yee

  • Adaptive Randomization of Neratinib in Early Breast Cancer

    John W Park;Minetta C Liu;Douglas Yee;Christina Yau

  • Safety and Efficacy of Weight Training in Recent Breast Cancer Survivors to Alter Body Composition, Insulin, and Insulin-Like Growth Factor Axis Proteins

    Kathryn H. Schmitz;Rehana L. Ahmed;Peter J. Hannan;Douglas Yee

  • In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.

    Patrick J. Bolan;Sina Meisamy;Eva H. Baker;Joseph Lin

  • Quantum dots for cancer diagnosis and therapy: Biological and clinical perspectives

    Hua Zhang;Douglas Yee;Chun Wang

  • Insulin-like growth factor II mRNA expression in human breast cancer.

    Douglas Yee;Kevin J. Cullen;Soonmyoung Paik;James F. Perdue

  • IGF System and Breast Cancer

    Marc A. Becker;Douglas Yee

Frequent Co-Authors

Laura J. Esserman
Laura J. Esserman University of California, San Francisco
Angela DeMichele
Angela DeMichele University of Pennsylvania
Donald A. Berry
Donald A. Berry The University of Texas MD Anderson Cancer Center
Christina Yau
Christina Yau University of California, San Francisco
Laura J. van't Veer
Laura J. van't Veer University of California, San Francisco
Kathy S. Albain
Kathy S. Albain Loyola University Chicago
Anthony D. Elias
Anthony D. Elias University of Colorado Boulder
Hope S. Rugo
Hope S. Rugo University of California, San Francisco
Judy C. Boughey
Judy C. Boughey Mayo Clinic
Claudine Isaacs
Claudine Isaacs Georgetown University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering studying medicine in the USA, it's worth exploring related online healthcare degrees and career advancements. For aspiring nurses, there are many affordable online nursing programs that deliver quality education with scheduling flexibility, making it easier to balance life and studies.

For those who already hold an RN license, advancing your credentials can be more accessible and affordable with the cheapest accredited online rn to bsn programs. These programs can open up more senior clinical roles and specialization opportunities.

If your goal is leadership or academia in nursing, you might consider the benefits of phd nursing education online. These programs prepare graduates for advanced research, teaching, and executive positions in healthcare.

For individuals with a non-nursing bachelor’s degree looking to shift careers, direct entry np programs for non nurses online provide a fast-track pathway to become a nurse practitioner, further broadening opportunities within the healthcare sector.

Best Scientists Citing Douglas Yee

Trending Scientists

Recently Published Articles